Jasbir Seehra Keros Therapeutics, Inc. (KROS) insider trading activity

KROS Quotes by TradingView

Jasbir Seehra is CHIEF EXECUTIVE OFFICER of Keros Therapeutics, Inc.. Currently has a direct ownership of 392,723 shares of KROS, which is worth approximately $5.4 Million. The most recent transaction as insider was on Sep 03, 2025, when has been sold 90,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 393K
29.94% 3M change
55.31% 12M change
Total Value Held $5.4 Million

Jasbir Seehra Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2025
BUY
Grant, award, or other acquisition
-
90,500 Added 18.73%
392,723 Common Stock
Apr 04 2025
BUY
Exercise of conversion of derivative security
$14,810 $0.3 p/Share
49,367 Added 14.04%
302,223 Common Stock
Apr 08 2023
BUY
Exercise of conversion of derivative security
$1,920 $0.48 p/Share
4,000 Added 1.56%
252,856 Common Stock
Jun 09 2022
BUY
Exercise of conversion of derivative security
$1,500 $0.3 p/Share
5,000 Added 1.97%
248,856 Common Stock

Also insider at

ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
Director
JS

Jasbir Seehra

CHIEF EXECUTIVE OFFICER
Lexington, MA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS